BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
97 results:

  • 1. Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.
    Zhuang M; Li F; Liang H; Su Y; Cheng L; Lin B; Zhou J; Deng R; Chen L; Lyu P; Lu Z
    Cell Death Dis; 2024 Apr; 15(4):241. PubMed ID: 38561375
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
    Patrizi S; Miele E; Falcone L; Vallese S; Rossi S; Barresi S; Giovannoni I; Pedace L; Nardini C; Masier I; Abballe L; Cacchione A; Russo I; Di Giannatale A; Di Ruscio V; Salgado CM; Mastronuzzi A; Ciolfi A; Tartaglia M; Milano GM; Locatelli F; Alaggio R
    Clin Epigenetics; 2024 Jan; 16(1):9. PubMed ID: 38178234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics.
    Lee CY; The M; Meng C; Bayer FP; Putzker K; Müller J; Streubel J; Woortman J; Sakhteman A; Resch M; Schneider A; Wilhelm S; Kuster B
    Mol Syst Biol; 2024 Jan; 20(1):28-55. PubMed ID: 38177929
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57
    Pomella S; Cassandri M; D'Archivio L; Porrazzo A; Cossetti C; Phelps D; Perrone C; Pezzella M; Cardinale A; Wachtel M; Aloisi S; Milewski D; Colletti M; Sreenivas P; Walters ZS; Barillari G; Di Giannatale A; Milano GM; De Stefanis C; Alaggio R; Rodriguez-Rodriguez S; Carlesso N; Vakoc CR; Velardi E; Schafer BW; Guccione E; Gatz SA; Wasti A; Yohe M; Ignatius M; Quintarelli C; Shipley J; Miele L; Khan J; Houghton PJ; Marampon F; Gryder BE; De Angelis B; Locatelli F; Rota R
    Nat Commun; 2023 Dec; 14(1):8373. PubMed ID: 38102140
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epidemiology of adenosarcoma and the inverse probability of treatment weighting (IPTW) adjusted survival analysis of lymph node dissection in uterine adenosarcoma.
    Hu H; Wei Z; Zhao H; Yuan G
    Medicine (Baltimore); 2022 Sep; 101(38):e30607. PubMed ID: 36197202
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 kip1.
    Gu J; Dai B; Shi X; He Z; Xu Y; Meng X; Zhu J
    Aging (Albany NY); 2021 Sep; 13(17):21743-21757. PubMed ID: 34518440
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway.
    Gao LF; Jia S; Zhang QM; Xia YF; Li CJ; Li YH
    Clin Transl Oncol; 2022 Feb; 24(2):266-275. PubMed ID: 34318428
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells.
    Muscella A; Stefàno E; De Bellis L; Nutricati E; Negro C; Marsigliante S
    Ann N Y Acad Sci; 2021 Sep; 1500(1):34-47. PubMed ID: 33960434
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma.
    Wang J; Aldahamsheh O; Ferrena A; Borjihan H; Singla A; Yaguare S; Singh S; Viscarret V; Tingling J; Zi X; Lo Y; Gorlick R; Zheng D; Schwartz EL; Zhao H; Yang R; Geller DS; Hoang BH
    Ann N Y Acad Sci; 2021 Apr; 1490(1):90-104. PubMed ID: 33594717
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation.
    Petragnano F; Pietrantoni I; Di Nisio V; Fasciani I; Del Fattore A; Capalbo C; Cheleschi S; Tini P; Orelli S; Codenotti S; Mazzei MA; D'Ermo G; Pannitteri G; Tombolini M; De Cesaris P; Riccioli A; Filippini A; Milazzo L; Vulcano F; Fanzani A; Maggio R; Marampon F; Tombolini V
    Int J Radiat Biol; 2020 Jun; 96(6):823-835. PubMed ID: 32149569
    [No Abstract]    [Full Text] [Related]  

  • 11. RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
    Kohlmeyer JL; Kaemmer CA; Pulliam C; Maharjan CK; Samayoa AM; Major HJ; Cornick KE; Knepper-Adrian V; Khanna R; Sieren JC; Leidinger MR; Meyerholz DK; Zamba KD; Weimer JM; Dodd RD; Darbro BW; Tanas MR; Quelle DE
    Clin Cancer Res; 2020 Jun; 26(12):2997-3011. PubMed ID: 32086342
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mislocalized cytoplasmic p27 activates PAK1-mediated metastasis and is a prognostic factor in osteosarcoma.
    Chen X; Cates JMM; Du YC; Jain A; Jung SY; Li XN; Hicks JM; Man TK
    Mol Oncol; 2020 Apr; 14(4):846-864. PubMed ID: 31872963
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epithelioid sarcoma in children, adolescents, and young adults: Localized, primary metastatic and relapsed disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Sparber-Sauer M; Koscielniak E; Vokuhl C; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Ladenstein R; Fuchs J; Klingebiel T;
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27879. PubMed ID: 31215116
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. p27/kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma.
    Currier AW; Kolb EA; Gorlick RG; Roth ME; Gopalakrishnan V; Sampson VB
    Sci Rep; 2019 Apr; 9(1):6161. PubMed ID: 30992462
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic factors of patients with extremity myxoid liposarcomas after surgery.
    Wu J; Qian S; Jin L
    J Orthop Surg Res; 2019 Mar; 14(1):90. PubMed ID: 30922351
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting cdkn1b/p27.
    Hu XH; Zhao ZX; Dai J; Geng DC; Xu YZ
    J Cell Biochem; 2019 Mar; 120(3):4665-4674. PubMed ID: 30582227
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma.
    Ghayad SE; Rammal G; Sarkis O; Basma H; Ghamloush F; Fahs A; Karam M; Harajli M; Rabeh W; Mouawad JE; Zalzali H; Saab R
    Cancer Biol Ther; 2019; 20(3):272-283. PubMed ID: 30307360
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.
    Zhang HT; Gui T; Sang Y; Yang J; Li YH; Liang GH; Li T; He QY; Zha ZG
    J Cell Biochem; 2017 Aug; 118(8):2182-2192. PubMed ID: 28059436
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Galangin suppresses human osteosarcoma cells: An exploration of its underlying mechanism.
    Yang Z; Li X; Han W; Lu X; Jin S; Yang W; Li J; He W; Qian Y
    Oncol Rep; 2017 Jan; 37(1):435-441. PubMed ID: 27840963
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma.
    Hayashi T; Kawano M; Ichimura T; Ida K; Ando H; Zharhary D; Kanai Y; Aburatani H; Tonegawa S; Shiozawa T; Yaegashi N; Konishi I
    Anticancer Res; 2016 Oct; 36(10):4997-5007. PubMed ID: 27798858
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.